Charles A. Reinhart, III

Former Chief Financial OfficeratPacira BioSciences· In proxies 2021–2024

Pay in FY2024-10% from the year before · Pacira BioSciences stock -44.2% the same year

Charles A. Reinhart, III was paid $1.3M in FY2024 (Dec), down 10%. Pacira BioSciences stock fell 44.2% that year.

Pay$100 in the stock at the end of FY20 → $31

Pay is from the Summary Compensation Table of each Pacira BioSciences proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

Pacira BioSciencesPublic company · 5 yr
- Former Chief Financial Officer2021 – Present · 5 yrStock in role -39%

Roles come from the proxy statements of each company.

Activity

Pay
Pacira BioSciences Former CFO pay fell 10% to $1.3M. The stock fell 44% in FY2024 (Dec).
DEF 14AApr 29, 2025
Pay
Pacira BioSciences Former CFO pay fell 18% to $1.4M. The stock fell 13% in FY2023 (Dec).
DEF 14AApr 22, 2024

For the press:Download CSV Download PNG How to use our data

Two people shown as one, or a wrong number?